Clinical Trials Logo
  1. Home
  2. Olfaction Disorders
  3. NCT04696601

Rapid Screening for Olfactory Disorders in Covid-19 Infection — OLFASCAN  

Olfaction Disorders Clinical Trial

Official title:
Rapid Screening for Olfactory Disorders in Covid-19 Infection

Clinical Trial Summary

Loss of smell is very frequently found in Europe during Covid-19 attack. This symptom was not initially expected as part of the classic symptomatology. This loss of smell mainly concerns patients with few or no symptoms, without criteria of severity and usually treated on an outpatient basis. As a result, given the unexpected occurrence of this symptom (with less awareness in the general and medical population) and the potential risk of contamination of Covid+ and anosmic subjects (due to their less symptomatic form), it is interesting to be able to propose large-scale screening for loss of sense of smell in order to preferentially direct subjects diagnosed as anosmic towards RT-PCR-type screening. In the medium term, the loss of smell seems to persist after the infectious phase, with delayed or persistent recovery, which can lead to negative psychological repercussions. The objective is to propose large-scale screening of the general population for loss of sense of smell during a pandemic period, in order to facilitate diagnostic orientation of the population. The diagnosis of loss of smell will be carried out using a simple olfactory test in the form of an olfactory stick to be smelled.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04696601
Study type Interventional
Source Centre Hospitalier Universitaire de Nice
Contact
Status Withdrawn
Phase N/A
Start date January 8, 2021
Completion date January 1, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT04526054 - Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients N/A
Recruiting NCT04799977 - COVID-19: Post-covid Olfactory Disorders Assessment
Completed NCT04529161 - Olfactory and Taste Changes During Fasting Mimicking Diet (FMD) N/A
Completed NCT00660868 - Is Pentoxifylline Able to Improve Olfactory Sensitivity? N/A
Completed NCT04361474 - Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity Phase 3
Withdrawn NCT01814618 - Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery Phase 2
Completed NCT03698760 - Computerized Olfactory Test - Alzheimer Disease Mild Stage N/A
Completed NCT04406584 - Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction N/A
Completed NCT02565121 - Olfaction Disorders in Patients Included in The Trauma Brain Injury (TBI) Database at Trondheim University Hospital N/A
Recruiting NCT05364125 - Olfactory Training on Smell Dysfunction Patients in HK N/A
Recruiting NCT04598763 - Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive N/A
Terminated NCT04104594 - Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal Polyps N/A
Withdrawn NCT03043144 - Taste And Smell TEsting in End Stage Renal Disease N/A
Recruiting NCT06204432 - Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction Phase 2
Recruiting NCT04390646 - GnRH Therapy on Cognition in Down Syndrome Phase 2/Phase 3
Enrolling by invitation NCT05666492 - "Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction. N/A